The healthcare giant just delivered another strong quarter, and Wall Street's starting to pay attention.
Zacks Investment Research on MSN
Johnson & Johnson (JNJ) is attracting investor attention: Here is what you should know
Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...
A California jury on Friday awarded $40 million to two women who said Johnson & Johnson‘s baby powder was to blame for their ovarian cancer. Erik Haas, Johnson & Johnson‘s worldwide vice president of ...
Morgan Stanley believes that Johnson and Johnson has stronger earnings potential driven by its robust product cycle. The bank ...
As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.
Litigation firm Beasley Allen must stop representing plaintiffs suing Johnson & Johnson over exposure to talc products, a New Jersey state court ruled Friday in a landmark ethics decision.
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results